Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Borrok MJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Borrok MJ; Janssen BioTherapeutics, Spring House, Pennsylvania.; M. Jack Borrok and Yonghai Li contributed equally to this article., Li Y; Janssen BioTherapeutics, Spring House, Pennsylvania.; M. Jack Borrok and Yonghai Li contributed equally to this article., Harvilla PB; Janssen BioTherapeutics, Spring House, Pennsylvania., Vellalore Maruthachalam B; Janssen BioTherapeutics, Spring House, Pennsylvania., Tamot N; Janssen BioTherapeutics, Spring House, Pennsylvania., Prokopowitz C; Janssen BioTherapeutics, Spring House, Pennsylvania., Chen J; Janssen BioTherapeutics, Spring House, Pennsylvania., Venkataramani S; Janssen BioTherapeutics, Spring House, Pennsylvania., Grewal IS; Janssen BioTherapeutics, Spring House, Pennsylvania., Ganesan R; Janssen BioTherapeutics, Spring House, Pennsylvania., Singh S; Janssen BioTherapeutics, Spring House, Pennsylvania.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Mar 22; Vol. 2 (3), pp. 146-157. Date of Electronic Publication: 2022 Mar 22 (Print Publication: 2022).
Autor:
Shan L; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA. shan@dnli.com.; Denali Therapeutics, South San Francisco, CA, USA. shan@dnli.com., Dyk NV; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Haskins N; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Cook KM; Early Oncology, R&D, AstraZeneca, Gaithersburg, MD, USA., Rosenthal KL; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Mazor R; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA.; Division of Cellular and Gene Therapies, FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Dragulin-Otto S; Dosage Form Design and Development, R&D, AstraZeneca, Gaithersburg, MD, USA., Jiang Y; Clinical Pharmacology and Safety Science, R&D, AstraZeneca, Gaithersburg, MD, USA., Wu H; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Dall'Acqua WF; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Borrok MJ; Janssen BioTherapeutics, Janssen Research and Development, Spring House, PA, USA., Damschroder MM; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA., Oganesyan V; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, MD, USA. vaheh.oganesyan@AstraZeneca.com.
Publikováno v:
Communications biology [Commun Biol] 2021 Sep 08; Vol. 4 (1), pp. 1048. Date of Electronic Publication: 2021 Sep 08.
Autor:
Allen KL, Cann J, Zhao W, Peterson N, Lazzaro M, Zhong H, Wu H, Dall'Acqua WF, Borrok MJ, Damschroder MM, Tsui P, Li Q
Publikováno v:
PloS one [PLoS One] 2021 May 17; Vol. 16 (5), pp. e0252060. Date of Electronic Publication: 2021 May 17 (Print Publication: 2021).
Autor:
White I; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Tamot N; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Doddareddy R; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Ho J; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Jiao Q; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Harvilla PB; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Yang TY; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Geist B; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Borrok MJ; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Truppo MD; Active Pharmaceutical Ingredient Development, Janssen R&D LLC, Spring House, PA, USA., Ganesan R; Biologics Discovery, Alector, Inc., South San Francisco, CA, USA., Chowdhury P; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Zwolak A; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA.
Publikováno v:
MAbs [MAbs] 2021 Jan-Dec; Vol. 13 (1), pp. 1987180.
Autor:
Allen KL; Department of Antibody Discovery & Protein Engineering, AstraZeneca plc, Gaithersburg, MD, United States of America., Cann J; Department of Clinical Pharmacology & Safety Sciences, AstraZeneca plc, Gaithersburg, MD, United States of America., Zhao W; Department of Clinical Pharmacology & Safety Sciences, AstraZeneca plc, Gaithersburg, MD, United States of America., Peterson N; Department of Clinical Pharmacology & Safety Sciences, AstraZeneca plc, Gaithersburg, MD, United States of America., Lazzaro M; Department of Oncology, AstraZeneca, AstraZeneca plc, Gaithersburg, MD, United States of America., Zhong H; Department of Oncology, AstraZeneca, AstraZeneca plc, Gaithersburg, MD, United States of America., Wu H; Department of Antibody Discovery & Protein Engineering, AstraZeneca plc, Gaithersburg, MD, United States of America., Dall'Acqua WF; Department of Antibody Discovery & Protein Engineering, AstraZeneca plc, Gaithersburg, MD, United States of America., Borrok MJ; Department of Antibody Discovery & Protein Engineering, AstraZeneca plc, Gaithersburg, MD, United States of America., Damschroder MM; Department of Antibody Discovery & Protein Engineering, AstraZeneca plc, Gaithersburg, MD, United States of America., Tsui P; Department of Antibody Discovery & Protein Engineering, AstraZeneca plc, Gaithersburg, MD, United States of America., Li Q; Department of Antibody Discovery & Protein Engineering, AstraZeneca plc, Gaithersburg, MD, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 Jun 04; Vol. 15 (6), pp. e0234268. Date of Electronic Publication: 2020 Jun 04 (Print Publication: 2020).
Autor:
Li Q, Chan C, Peterson N, Hanna RN, Alfaro A, Allen KL, Wu H, Dall'Acqua WF, Borrok MJ, Santos JL
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2020 Apr 17; Vol. 15 (4), pp. 830-836. Date of Electronic Publication: 2020 Mar 13.